Skip to content
healthcare.dev

GLYDO- lidocaine hydrochloride jelly

NDC 51662-1652, GLYDO- lidocaine hydrochloride jelly, jelly, from HF Acquisition Co. LLC, DBA HealthFirst.

Product NDC
51662-1652
Status
Listed
Labeler
HF Acquisition Co. LLC, DBA HealthFirst
Dosage form
JELLY
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201094
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1652 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIDOCAINE HYDROCHLORIDE ANHYDROUS20 mg/mL

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
51662-1652-1516621652011 SYRINGE in 1 SYRINGE (51662-1652-1) / 6 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3364b25d-bf30-c028-e063-6394a90a8008

Use it

Look up 51662-1652 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1652 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51662-1652. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.